(Approval lapsed) Atropine Sulfate 600 micrograms in 1mL Solution for injection ampoule
Section 19A approved medicine
(Approval lapsed) Atropine Sulfate 600 micrograms in 1mL Solution for injection ampoule
Section 19A approval holder
Orpharma Pty Ltd ABN 19 157 901 267
Phone
03 9863 7501
Approved until
Status
Expired
Medicines in short supply/unavailable
Pfizer (Perth) ATROPINE INJECTION BP atropine sulfate monohydrate 600 microgram/1 mL injection BP ampoule - ARTG 11302
Indication(s)
- Preanaesthetic medication to reduce salivary secretions and bronchial secretions
- to prevent cholinergic cardiac effects such as cardiac arrhythmias, hypotension and bradycardia
- management of patients with acute myocardial infarction and sinus bradycardia who have associated hypotension and increased ventricular irritability
- concurrent administration with anticholinesterase agents (e.g. neostigmine, physostigmine) to block the adverse muscarinic effects of these agents following surgery to terminate curarisation
- for poisoning by organophosphate pesticides, atropine may be used concomitantly with a cholinesterase reactivator such as pralidoxime to reverse muscarinic effects.